VAdriaC
Term · Oncology and biomedicine · MLC-T-ONC-009134
An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Also called VAdriaC regimen.
| Identifier | MLC-T-ONC-009134 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | VAdriaC regimen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009134",
"term": "VAdriaC",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Also called VAdriaC regimen.",
"synonyms": [
"VAdriaC regimen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/vadriac/"
}
Record 17,069 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.